New Key Statistics Module, Z-Score and F-Score
OTCPK:EPGNF Key Ratios
| Market Cap $ M | 1.37 |
| Enterprise Value $ M | -2.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.68 |
| Price/Sales | 2.82 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -20.83 |
| Beneish M-Score | 24.58 |
| 10-y EBITDA Growth Rate % | 22.20 |
| 5-y EBITDA Growth Rate % | 38.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.12 |
| EV-to-EBITDA | 0.14 |
| PEG | -- |
| Shares Outstanding M | 0.85 |
| Net Margin (%) | -3,636.16 |
| Operating Margin % | -4,071.65 |
| Pre-tax Margin (%) | -3,653.35 |
| Quick Ratio | 1.93 |
| Current Ratio | 1.93 |
| ROA % (ttm) | -115.14 |
| ROE % (ttm) | -172.48 |
| ROIC % (ttm) | -395.97 |
| Dividend Yield % | -- |
| Altman Z-Score | -46.45 |
EPGNF Number of Guru Trades
EPGNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:EPGNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:EPGNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Epigenomics AG Insider Transactions
No Available Data
News about OTCPK:EPGNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers